NCT04758468

Brief Summary

The effectiveness of pelvic floor muscle training on urinary incontinence and sexual function has been known for many years. However, the evaluation of its effectiveness in people with Multiple Sclerosis (MS) has recently begun and the level of evidence is limited. In addition, the applicability of pelvic floor muscle training based on telerehabilitation in the presence of a physiotherapist has not been investigated before. The aims of this study;

  1. 1.The main aim of this study is to evaluate the feasibility and acceptability of telerehabilitation-based pelvic floor muscle training under the guidance of a physiotherapist, which will be applied for the first time.
  2. 2.Another aim is to compare this method with the effects of not receiving treatment other than usual treatment or receiving home-based pelvic floor muscle training on urinary incontinence, sexual dysfunction and psychosocial outcomes.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
45

participants targeted

Target at P50-P75 for not_applicable multiple-sclerosis

Timeline
Completed

Started Feb 2021

Shorter than P25 for not_applicable multiple-sclerosis

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 11, 2021

Completed
6 days until next milestone

First Posted

Study publicly available on registry

February 17, 2021

Completed
1 day until next milestone

Study Start

First participant enrolled

February 18, 2021

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 15, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 15, 2021

Completed
Last Updated

March 29, 2022

Status Verified

March 1, 2022

Enrollment Period

9 months

First QC Date

February 11, 2021

Last Update Submit

March 26, 2022

Conditions

Keywords

Multiple SclerosisUrinary IncontinencePelvic Floor Muscle TrainingSexual Function

Outcome Measures

Primary Outcomes (5)

  • Feasibility of the methods-minimum recruitment rate

    A minimum recruitment rate of 10 participants per month will be accepted as feasible.

    Through Study Completion, an Average of 8 Weeks

  • Feasibility of the methods-minimum retention rate

    A target retention rate of 80% will be accepted as feasible.

    Through Study Completion, an Average of 8 Weeks

  • Feasibility of the methods-minimum adherence rate

    A target minimum adherence rate of 70% of the overall practice sessions will be accepted as feasible.

    Through Study Completion, an Average of 8 Weeks

  • Feasibility of the methods-adverse events

    A record sheet was prepared for possible adverse events during the tests and intervention. It includes information about seriousness, expectedness, severity, causality, time, duration of the event and clinical action taken. The numbers of adverse events will be reported.

    Through Study Completion, an Average of 8 Weeks

  • Change in Leakage Episodes

    The bladder diary is a form that is used to objectively evaluate the frequency and severity of urinary incontinence. It will be used to determine the leakage episodes. It will be filled in three days by the patients. The amount of fluid taken in the diary, the amount of urine, the number of incontinence and pad change are recorded.

    The assessments will be applied at baseline, 4, 8, and 12 weeks.

Secondary Outcomes (12)

  • Expanded Disability Status Scale (EDSS)

    The assessment will be applied at baseline.

  • Change in Patient-Determined Disease Steps Scale (PDDS) Score

    The assessments will be applied at baseline and 8 weeks.

  • Change in Brief International Cognitive Assessment for MS-Symbol Digit Modalities Test Score

    The assessments will be applied at baseline and 8 weeks.

  • Change in Brief International Cognitive Assessment for MS-California Verbal Learning Test-Second Edition Score

    The assessments will be applied at baseline and 8 weeks.

  • Change in Brief International Cognitive Assessment for MS-Brief Visuospatial Memory Test-Revised Score

    The assessments will be applied at baseline and 8 weeks.

  • +7 more secondary outcomes

Study Arms (3)

Telerehabilitation-based pelvic floor muscle training

EXPERIMENTAL
Behavioral: Telerehabilitation-based pelvic floor muscle training

Home-based pelvic floor muscle training

ACTIVE COMPARATOR
Behavioral: Home-based pelvic floor muscle training

Control (no specific intervention)

NO INTERVENTION

Interventions

Telerehabilitation-based pelvic floor muscle training group will individually receive telerehabilitation-based pelvic floor muscle training under the guidance of a physiotherapist 2 sessions per week for 8 weeks. Participants will do their exercises themselves 2 times on the days where sessions are held with a physiotherapist. Participants will continue to exercise 3 times a day in the remaining days. Both intervention groups will follow the same pelvic floor muscle training protocol for 8 weeks.

Telerehabilitation-based pelvic floor muscle training

The home-based pelvic floor muscle training group will do their individual exercises 3 times a day for 8 weeks. Both intervention groups will follow the same pelvic floor muscle training protocol for 8 weeks.

Home-based pelvic floor muscle training

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Having been diagnosed with MS according to McDonald diagnostic criteria
  • Having urinary incontinence
  • EDSS score less than 8
  • Have the cognitive capacity to complete the assessment and treatment protocol

You may not qualify if:

  • Pregnancy
  • Pelvic surgery history
  • A history of cesarean or vaginal delivery within 6 months prior to the study
  • Progressive disability (1 point increase in EDSS) or attacks in the last 3 months
  • Having received pelvic floor muscle training in the last 6 months
  • Have had or are receiving treatment for pelvic organ prolapse Patients receiving pharmacological therapy for incontinence whose dose has not changed over the past 3 months will be included, but will be excluded if the dose changes during the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Dokuz Eylul University Hospital, MS Outpatient Clinic

Izmir, Inciralti, 35340, Turkey (Türkiye)

Location

Related Publications (1)

  • Yavas I, Kahraman T, Sagici O, Ozdogar AT, Yigit P, Baba C, Ozakbas S. Feasibility of Telerehabilitation-Based Pelvic Floor Muscle Training for Urinary Incontinence in People With Multiple Sclerosis: A Randomized, Controlled, Assessor-Blinded Study. J Neurol Phys Ther. 2023 Oct 1;47(4):217-226. doi: 10.1097/NPT.0000000000000448. Epub 2023 Jun 12.

MeSH Terms

Conditions

Multiple SclerosisUrinary Incontinence

Condition Hierarchy (Ancestors)

Demyelinating Autoimmune Diseases, CNSAutoimmune Diseases of the Nervous SystemNervous System DiseasesDemyelinating DiseasesAutoimmune DiseasesImmune System DiseasesUrination DisordersUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital DiseasesLower Urinary Tract SymptomsUrological ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

February 11, 2021

First Posted

February 17, 2021

Study Start

February 18, 2021

Primary Completion

November 15, 2021

Study Completion

November 15, 2021

Last Updated

March 29, 2022

Record last verified: 2022-03

Data Sharing

IPD Sharing
Will not share

Locations